{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:44:50Z","timestamp":1794620690131,"version":"4.9.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Homeostatic model assessment for insulin resistance (HOMA-IR) and triglyceride glucose (TyG) index\u2013related parameters [TyG index, triglyceride glucose\u2013waist circumference (TyG-WC), triglyceride glucose\u2013waist-to-height ratio (TyG-WHtR), and triglyceride glucose\u2013body mass index (TyG-BMI)] are gradually considered as convenient and alternative indicators for insulin resistance in various metabolic diseases, but the specific diagnostic capacity and the comparison of the parameters in non-alcoholic fatty liver disease (NAFLD), metabolic-associated fatty liver disease (MAFLD), and liver fibrosis remain uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To comprehensively assess and compare the diagnostic accuracy of the above parameters in NAFLD, MAFLD, and liver fibrosis and identify the appropriate indicators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 1,727 adults were enrolled from the 2017\u20132018 National Health and Nutrition Examination Surveys. Logistic regressions were used to identify the parameters significantly associated with NAFLD, MAFLD, and liver fibrosis; receiver operating characteristic (ROC) curves were used to evaluate and compare their diagnostic capacity. Subgroup analyses were conducted to validate the concordance, and the optimal cutoff values were determined according to the Youden\u2019s indexes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Significant differences were observed between quartile-stratified HOMA-IR and TyG index\u2013related parameters across the NAFLD, MAFLD, and liver fibrosis (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05). All variables were significantly predictive of different disease states (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05). The top three AUC values are TyG-WC, TyG-WHtR, and TyG-BMI with AUCs of 0.815, 0.809, and 0.804 in NAFLD. The optimal cutoff values were 822.34, 4.94, and 237.77, respectively. Similar values and the same trend of the above three indexes could be observed in MAFLD and liver fibrosis. Subgroup analyses showed consistent results with the primary research, despite some heterogeneity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TyG-WC, TyG-WHtR, and TyG-BMI can be used for early screening of NAFLD and MAFLD. These three parameters and HOMA-IR were more suitable for assessing metabolic risks and monitoring disease progression in patients with NAFLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2022.951689","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T15:46:09Z","timestamp":1662133569000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":207,"title":["Potential screening indicators for early diagnosis of NAFLD\/MAFLD and liver fibrosis: Triglyceride glucose index\u2013related parameters"],"prefix":"10.3389","volume":"13","author":[{"given":"Yan","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqiu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of nafld and nash: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B2","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J Clin invest"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.05.064","article-title":"Toward more accurate nomenclature for fatty liver diseases","volume":"157","author":"Eslam","year":"2019","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.06.064","article-title":"Real-world burden of nonalcoholic steatohepatitis","volume":"19","author":"Geier","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-019-0145-7","article-title":"From nash to hcc: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2018-317593","article-title":"Advances in non-invasive assessment of hepatic fibrosis","volume":"69","author":"Loomba","year":"2020","journal-title":"Gut"},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in nafld and nash - current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.1002\/hep.30429","article-title":"Modulation of insulin resistance in nonalcoholic fatty liver disease","volume":"70","author":"Khan","year":"2019","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.2337\/diacare.24.2.362","article-title":"Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes","volume":"24","author":"Katsuki","year":"2001","journal-title":"Diabetes Care"},{"key":"B14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12944-021-01561-2","article-title":"The usefulness of obesity and lipid-related indices to predict the presence of non-alcoholic fatty liver disease","volume":"20","author":"Sheng","year":"2021","journal-title":"Lipids Health Dis"},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-021-02815-w","article-title":"Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus","volume":"74","author":"Malek","year":"2021","journal-title":"Endocrine"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1111\/j.1572-0241.2007.01322.x","article-title":"Usefulness of a combined evaluation of the serum adiponectin level, homa-ir, and serum type iv collagen 7s level to predict the early stage of nonalcoholic steatohepatitis","volume":"102","author":"Shimada","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.12.029","article-title":"Prevalence of high-risk nonalcoholic steatohepatitis (nash) in the united states: results from nhanes 2017-2018","author":"Vilar-Gomez","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2018.04.043","article-title":"Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease","volume":"17","author":"Siddiqui","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of fibroscan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"B20","unstructured":"Centers for disease control and prevention 2017: national health and nutrition examination survey (nhanes). us department of health and human services2017"},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2017.1658","article-title":"Income disparities in absolute cardiovascular risk and cardiovascular risk factors in the united states, 1999-2014","volume":"2","author":"Odutayo","year":"2017","journal-title":"JAMA Cardiol"},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2021.08.009","article-title":"Associations of socioeconomic status and sleep disorder with depression among us adults","volume":"295","author":"Li","year":"2021","journal-title":"J Affect Disord"},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.14545","article-title":"Trends in blood pressure control among us adults with hypertension, 1999-2000 to 2017-2018","volume":"324","author":"Muntner","year":"2020","journal-title":"Jama"},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.2337\/dc10-1718","article-title":"Association between insulin resistance and development of microalbuminuria in type 2 diabetes: a prospective cohort study","volume":"34","author":"Hsu","year":"2011","journal-title":"Diabetes Care"},{"key":"B25","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"B26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/15438627.2018.1502183","article-title":"A new waist-to-height ratio predicts abdominal adiposity in adults","volume":"28","author":"Nevill","year":"2020","journal-title":"Res sports Med"},{"key":"B27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41598-020-80305-1","article-title":"Association of the triglyceride and glucose index with low muscle mass: knhanes 2008-2011","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"crossref","DOI":"10.1089\/met.2020.0109","article-title":"Triglyceride glucose index and related parameters (triglyceride glucose-body mass index and triglyceride glucose-waist circumference) identify nonalcoholic fatty liver and liver fibrosis in individuals with overweight\/obesity","volume":"19","author":"Khamseh","year":"2021","journal-title":"Metab Syndr Relat Disord"},{"key":"B29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2337\/dc20-1997","article-title":"Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: the need for systematic screening","volume":"44","author":"Lomonaco","year":"2021","journal-title":"Diabetes Care"},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.1111\/liv.14828","article-title":"Prevalence of nafld, mafld and associated advanced fibrosis in the contemporary united states population","volume":"41","author":"Ciardullo","year":"2021","journal-title":"Liver Int"},{"key":"B31","doi-asserted-by":"crossref","first-page":"154433","DOI":"10.1016\/j.metabol.2020.154433","article-title":"Mafld and risk of ckd","volume":"115","author":"Sun","year":"2021","journal-title":"Metabolism"},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v22.i10.3023","article-title":"Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease","volume":"22","author":"Motamed","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B33","doi-asserted-by":"crossref","DOI":"10.1210\/er.2019-00034","article-title":"The liver as an endocrine organ-linking nafld and insulin resistance","volume":"40","author":"Watt","year":"2019","journal-title":"Endocr Rev"},{"key":"B34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cmet.2009.10.007","article-title":"Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of camp response element-binding protein","volume":"10","author":"Erion","year":"2009","journal-title":"Cell Metab"},{"key":"B35","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2009.09.007","article-title":"Prevention of steatosis by hepatic jnk1","volume":"10","author":"Sabio","year":"2009","journal-title":"Cell Metab"},{"key":"B36","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1010112","article-title":"Childhood adiposity, adult adiposity, and cardiovascular risk factors","volume":"365","author":"Juonala","year":"2011","journal-title":"N Engl J Med"},{"key":"B37","doi-asserted-by":"crossref","DOI":"10.1037\/hea0000674","article-title":"Racial discrimination, body mass index, and insulin resistance: a longitudinal analysis","volume":"37","author":"Brody","year":"2018","journal-title":"Health Psychol"},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejogrb.2016.08.011","article-title":"Could \"a body shape index\" and \"waist to height ratio\" predict insulin resistance and metabolic syndrome in polycystic ovary syndrome","volume":"205","author":"Behboudi-Gandevani","year":"2016","journal-title":"Eur J obstet gynecol Reprod Biol"},{"key":"B39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.diabres.2018.07.029","article-title":"Stronger associations of waist circumference and waist-to-height ratio with diabetes than bmi in chinese adults","volume":"147","author":"Hou","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.1172\/JCI81507","article-title":"Abdominal obesity: a marker of ectopic fat accumulation","volume":"125","author":"Smith","year":"2015","journal-title":"J Clin invest"},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.38429.473310.AE","article-title":"Use of waist circumference to predict insulin resistance: retrospective study","volume":"330","author":"Wahrenberg","year":"2005","journal-title":"Bmj"},{"key":"B42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12944-017-0409-6","article-title":"The triglyceride and glucose index (tyg) is an effective biomarker to identify nonalcoholic fatty liver disease","volume":"16","author":"Zhang","year":"2017","journal-title":"Lipids Health Dis"},{"key":"B43","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.14595","article-title":"Homa-ir: an independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease","volume":"34","author":"Fujii","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"B44","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-017-4340-1","article-title":"Use of homa-ir to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study","volume":"60","author":"Isokuortti","year":"2017","journal-title":"Diabetologia"},{"key":"B45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2021.07.035","article-title":"Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the united states","volume":"75","author":"Kim","year":"2021","journal-title":"J Hepatol"},{"key":"B46","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-019-05040-3","article-title":"Sex differences in metabolic regulation and diabetes susceptibility","volume":"63","author":"Tramunt","year":"2020","journal-title":"Diabetologia"},{"key":"B47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12944-021-01532-7","article-title":"Triglyceride glucose-body mass index and the risk of diabetes: a general population-based cohort study","volume":"20","author":"Wang","year":"2021","journal-title":"Lipids Health Dis"},{"key":"B48","doi-asserted-by":"crossref","first-page":"109042","DOI":"10.1016\/j.diabres.2021.109042","article-title":"The triglyceride-glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic model assessment of insulin resistance","volume":"180","author":"Park","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"B49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of nafld progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management","volume":"62","author":"Mcpherson","year":"2015","journal-title":"J Hepatol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.951689\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T19:02:07Z","timestamp":1676660527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.951689\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":49,"alternative-id":["10.3389\/fendo.2022.951689"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.951689","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2022.951689.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2022.951689.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2022.951689.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2022.951689.s004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2022.951689.s005","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2022.951689.s006","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2022.951689.s007","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2022.951689.s008","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2022.951689.s009","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2022.951689.s010","asserted-by":"subject"}]},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"article-number":"951689"}}